Israel Englander’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Israel Englander’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,774	Closed	-$294K	–	3634
2016 Q3	$294K	Buy	+4,774	New	+$313K	﹤0.01%	2825
2015 Q4	–	Sell	-4,306	Closed	-$286K	–	3700
2015 Q3	$286K	Buy	+4,306	New	+$335K	﹤0.01%	2933
2015 Q2	–	Sell	-18,790	Closed	-$1.44M	–	3717
2015 Q1	$1.44M	Buy	18,790 +14,217	+311%	+$1.04M	﹤0.01%	2153
2014 Q4	$304K	Buy	+4,573	New	+$305K	﹤0.01%	3345

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Israel Englander's PJP Position: Q4 2016 in Review

Israel Englander sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2016, closing a stake of 4,774 shares — an estimated $294K sold.

Israel Englander first reported a position in PJP in Q4 2014 and held it in 4 quarters. The position peaked at $1.44M in Q1 2015. 101 funds tracked by Wall St. Rank hold PJP as of Q4 2016.

Israel Englander reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2016 after selling out during the quarter.
Israel Englander sold 4,774 Invesco Pharmaceuticals ETF shares in Q4 2016, an estimated $294K.
Israel Englander first reported a position in Invesco Pharmaceuticals ETF in Q4 2014 and held it in 4 quarters.
Israel Englander's Invesco Pharmaceuticals ETF position peaked at $1.44M in Q1 2015.
101 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2016.

Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.